The bigger dog barks to its owner / slave....and you are then beaten.
First and foremost, Atossa Genetics has developed a tool (MASCT) that can save the lives of countless women through the early detection of breast cancer. The tool and procedure, which is non-invasive, trumps the radiation and needle biopsy tests, along with mammograms. Kudos to Atossa! Second, this has the potential to make investors a little money.
Sentiment: Strong Buy
This is going to blow up by weeks end.